Astellas Gets Europe Okay For AML Drug Xospata

Pulls Further Ahead Of Daiichi Sankyo's Rival FLT3 Inhibitor

 
• By Kevin Grogan
  
Check list
Astellas ticks off a third major approval for Xospata • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas